Kansas City, Mo. The privacy of patients affected by the investigation of a Kansas City pharmacist accused of diluting drugs will be protected, prosecutors say.
Prosecutors responded Thursday to a motion filed by physicians at Kansas City Internal Medicine, which obtained cancer medications from Robert Courtney's pharmacy. The doctors asked a federal judge to quash a subpoena for documents that included patient records.
The physicians said such records were covered by doctor-patient privilege and argued that doctors could face liability should they be disclosed.
Courtney is charged with 20 federal felony counts of tampering, misbranding and adulterating the chemotherapy drugs Gemzar and Taxol. He has pleaded innocent and is being held without bond.
Courtney reportedly told investigators he diluted the drugs out of greed.
Prosecutors said the government would bear any liability for disclosure of patient information, which they said was unlikely.